Aura 2016 Supplementary data

Table S4.30 Staphylococcus aureus resistance, by clinical setting, 2014

Antimicrobial	Public hospitals, % resistance (n)	Public hospitals and health services, % resistance (n)	Private hospitals, % resistance (n)	Community, % resistance (n)	Residential aged care facilities, % resistance (n)
Penicillin	82.7 (2 144)	88.9 (29 575)	84.4 (2 861)	84.6 (13)	na
Oxacillin	19.2 (2 144)	20.7 (29 504)	15.6 (3 493)	10.8 (34 117)	27.7 (1 901)
Erythromycin	17.2 (2 144)	14.7 (29 532)	19.6 (3 494)	17.3 (34 120)	22.2 (1 900)
Clindamycin	4.4 (2 144)	10.1 (29 834)	17.5 (3 492)	16.5 (34 105)	20.6 (1 899)
Tetracycline	6.1 (2 144)	3.3 (28 232)	4.5 (3 425)	3.2 (30 386)	5.0 (1 896)
Gentamicin	4.3 (2 146)	1.4 (29 206)	0.0 (60)	na	na
Ciprofloxacin	12.3 (2 146)	4.1 (28 213)	3.3 (60)	na	na
Trimethoprim–sulfamethoxazole	4.2 (2 144)	2.7 (29 294)	3.1 (3 494)	1.7 (34 120)	3.5 (1 901)
Fusidic acid	4.1 (2 145)	11.1 (28 125)	3.3 (60)	na	na
Rifampicin	0.4 (2 094)	0.2 (28 150)	0.0 (60)	na	na
Nitrofurantoin	0.0 (2 092)	na	0.0 (17)	na	na
Daptomycin	0.5 (2 142)	0.3 (26 344)	0.5 (3 047)	0.3 (30 852)	0.7 (1 649)
Linezolid	0.2 (2 146)	0.0 (26 180)	0.0 (3 048)	0.1 (30 863)	0.1 (1 649)
Vancomycin	0.0 (2 146)	0.0 (27 959)	0.0 (287)	0.0 (14)	na

na = not available (either not tested or tested against an inadequate number of isolates)

Sources: AGAR (public and private hospitals); OrgTRx, Queensland (public hospitals and health services); SNP (private hospitals, community and residential aged care facilities)

Table S4.31 Staphylococcus aureus resistance, by jurisdiction (blood culture isolates), 2014

Antimicrobial	ACT, % resistance (n)	NSW, % resistance (n)	NT, % resistance (n)	Qld, % resistance (n)	SA, % resistance (n)	Tas, % resistance (n)	Vic, % resistance (n)	WA, % resistance (n)	Australia, % resistance (n)
Penicillin	84.6 (78)	85.1 (516)	92.2 (64)	80.7 (550)	93.9 (196)	67.3 (52)	78.6 (426)	80.4 (322)	82.6 (2204)
Oxacillin	14.1 (78)	24.9 (515)	37.5 (64)	17.8 (550)	21.4 (196)	5.8 (52)	15.5 (426)	14.2 (323)	19.0 (2204)
Erythromycin	20.5 (78)	22.1 (516)	26.6 (64)	14.9 (550)	18.4 (196)	11.5 (52)	16.9 (425)	11.8 (323)	17.3 (2204)
Clindamycin	2.6 (78)	5.6 (516)	7.8 (64)	4.5 (550)	3.6 (196)	1.9 (52)	5.4 (425)	1.9 (323)	4.4 (2204)
Tetracycline	7.6 (79)	10.1 (516)	10.9 (64)	5.1 (550)	4.6 (194)	0.0 (52)	5.9 (426)	2.2 (323)	6.1 (2204)
Gentamicin	5.1 (79)	6.8 (516)	7.8 (64)	3.6 (550)	5.1 (196)	0.0 (52)	3.8 (426)	0.6 (323)	4.2 (2206)
Ciprofloxacin	13.9 (79)	19.6 (516)	9.4 (64)	8.4 (550)	13.3 (196)	1.9 (52)	12.9 (426)	6.2 (323)	12.1 (2206)
Trimethoprim–sulfamethoxazole	3.8 (79)	4.9 (515)	10.9 (64)	3.6 (550)	5.1 (195)	0.0 (52)	4.5 (426)	1.5 (323)	4.0 (2204)
Fusidic acid	0.0 (78)	4.3 (516)	3.1 (64)	6.9 (550)	4.1 (196)	0.0 (52)	2.6 (426)	3.1 (323)	4.2 (2205)
Rifampicin	0.0 (79)	0.6 (516)	0.0 (64)	0.0 (550)	1.0 (196)	na	0.7 (426)	0.3 (323)	0.4 (2154)
Nitrofurantoin	0.0 (79)	0.0 (516)	0.0 (64)	0.0 (505)	0.0 (196)	na	0.0 (426)	0.0 (323)	0.0 (2109)
Daptomycin	0.0 (77)	1.2 (515)	0.0 (64)	0.0 (549)	0.5 (196)	0.0 (52)	0.5 (426)	0.3 (323)	0.5 (2202)
Linezolid	0.0 (79)	0.4 (516)	0.0 (64)	0.0 (550)	0.0 (196)	0.0 (52)	0.2 (426)	0.3 (323)	0.2 (2206)
Vancomycin	0.0 (79)	0.0 (516)	0.0 (64)	0.0 (550)	0.0 (196)	0.0 (52)	0.0 (426)	0.0 (323)	0.0 (2206)

ACT = Australian Capital Territory; na = not available (either not tested or tested against an inadequate number of isolates); NSW = New South Wales; NT = Northern Territory; Qld = Queensland; SA = South Australia; Tas = Tasmania; Vic = Victoria; WA = Western Australia

Source: AGAR